What is the Sai Parenteral's Ltd share price today?

The share price of NSE:SAIPARENT-EQ on 01 Oct 2026 (as of 15:04:46 IST) is ₹523.

What is the NSE:SAIPARENT-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:SAIPARENT-EQ 52 week high low range shows a high of ₹706 and a low of ₹400.

What is the Sai Parenteral's Ltd market cap?

As on 01 Oct 2026, Sai Parenteral's Ltd market cap is ₹23359800000.

What is the shareholding pattern of Sai Parenteral's Ltd Stock?

The shareholding pattern of Sai Parenteral's Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 51.16% Foreign Institutional Investors (FII): 4.03% Domestic Institutional Investors (DII): 7.54% Mutual Funds: 0.98% Retail & Others: 36.29% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Sai Parenteral's Ltd?

The Price-to-Earnings (PE) ratio of Sai Parenteral's Ltd is 141.54, and the Price-to-Book (PB) ratio is 0, as on 01 Oct 2026.

Sai Parenteral's Share Price

505.90-15.75 (-3.02%)

+24.70% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-3.02%

1 Week

-3.39%

1 Month

-4.49%

3 Month

-13.98%

6 Month

+19.33%

YTD

1 Year

5 Year

10 Year

Max

+26.47%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

505.00

494.00

491.25

471.25

416.00

400.00

High

521.80

535.00

539.95

594.70

706.00

About

Sai Parenteral’s, along with its subsidiaries, carries out contract research and manufacturing activities for customers engaged in pharmaceutical industries. Its portfolio includes formulation products across various therapeutic areas like cardiovascular, Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

SAIPARENTNSE

LTP

1W Low

1W High

Market cap (₹)

1765.8-35.2 (-1.95%)

1762.80

1804.20

4,27,861Cr

9500+251 (2.71%)

9113.50

9660

2,54,319Cr

4630-137.3 (-2.88%)

4625

4795

1,79,153Cr

1115.2-30.5 (-2.66%)

1110.40

1167.40

1,15,112Cr

2023.1+39.1 (1.97%)

1955.10

2065.20

1,11,034Cr

1302.6-41.4 (-3.08%)

1302

1351

1,07,406Cr

2420-115 (-4.54%)

2407.80

2539.30

1,03,049Cr

1182.2-24 (-1.99%)

1180

1222.80

1,00,362Cr

1659.9-16.9 (-1.01%)

1646.50

1698.90

96,951Cr

1987-44.2 (-2.18%)

1983.60

2031.40

91,783Cr

505.9-17.75 (-3.39%)

494

535

2,309Cr

Sai Parenteral's Share Price

505.90-15.75 (-3.02%)

+24.70% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years58%

Last year134%

Compounded Profit Growth

10 years-

5 years-

3 years56%

Last year-1%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-

Return on Equity

10 years13%

5 years13%

3 years13%

Last year5%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	58%	134%
-	-	56%	-1%
-	-	-	-
13%	13%	13%	5%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

MANKIND

DRREDDY

AUROPHARMA

LUPIN

SAIPARENT

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,765.8	₹427861 Cr	35.37	12.07	62.82	₹11479 Cr
9,500	₹254319 Cr	86.95	34.04	128.41	₹2568 Cr
4,630	₹179153 Cr	82.14	16.72	97.06	₹2163 Cr
1,115.2	₹115112 Cr	25.51	9.42	62.53	₹5040 Cr
2,023.1	₹111034 Cr	101.55	6.8	29.25	₹889 Cr
1,302.6	₹107406 Cr	31.87	9.77	57.87	₹3879 Cr
2,420	₹103049 Cr	50.45	13.75	71.08	₹1913 Cr
1,182.2	₹100362 Cr	31.15	5.32	63.99	₹4196 Cr
1,659.9	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
1,987	₹91783 Cr	16.6	30.95	154.35	₹5333 Cr
505.9	₹2309 Cr	139.89	1.79	7.55	₹17 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Jun 2025
₹179 Cr	₹198 Cr	₹33 Cr
₹4 Cr	₹3 Cr	₹1 Cr
₹182 Cr	₹201 Cr	₹35 Cr
₹163 Cr	₹180 Cr	₹30 Cr
₹27 Cr	₹29 Cr	₹6 Cr
₹9 Cr	₹8 Cr	₹2 Cr
₹10 Cr	₹12 Cr	₹2 Cr
₹8 Cr	₹13 Cr	₹1 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023
—	—	—	—
₹22 Cr	₹13 Cr	₹13 Cr	₹7 Cr
₹469 Cr	₹80 Cr	₹61 Cr	₹24 Cr
₹469 Cr	₹80 Cr	₹61 Cr	₹24 Cr
₹491 Cr	₹94 Cr	₹75 Cr	₹31 Cr
₹4 Cr	₹2 Cr	₹2 Cr	₹0
₹80 Cr	₹12 Cr	₹36 Cr	₹26 Cr
₹11 Cr	₹2 Cr	₹3 Cr	₹0
-₹8 Cr	-₹52 L	-₹65 L	₹13 L
₹265 Cr	₹0	₹0	₹0
₹75 L	₹50 L	₹21 L	₹8 L
₹348 Cr	₹14 Cr	₹38 Cr	₹26 Cr
—	—	—	—
₹149 Cr	₹58 Cr	₹53 Cr	₹22 Cr
₹165 Cr	₹17 Cr	₹17 Cr	₹13 Cr
₹223 Cr	₹73 Cr	₹71 Cr	₹35 Cr
₹36 Cr	₹14 Cr	₹12 Cr	₹7 Cr
₹573 Cr	₹162 Cr	₹153 Cr	₹77 Cr
₹1416 Cr	₹272 Cr	₹267 Cr	₹134 Cr
₹6 Cr	₹2 Cr	₹4 Cr	₹2 Cr
₹319 Cr	₹94 Cr	₹119 Cr	₹69 Cr
—	—	—	—
₹432 Cr	₹79 Cr	₹99 Cr	₹55 Cr
₹68 Cr	₹26 Cr	₹29 Cr	₹11 Cr
₹364 Cr	₹53 Cr	₹70 Cr	₹44 Cr
₹212 Cr	₹50 L	₹0	₹2 Cr
₹16 Cr	₹17 Cr	₹9 Cr	₹5 Cr
₹2 Cr	₹1 Cr	₹61 L	₹92 L
₹594 Cr	₹72 Cr	₹80 Cr	₹52 Cr
—	—	—	—
₹172 Cr	₹51 Cr	₹37 Cr	₹13 Cr
₹181 Cr	₹127 Cr	₹127 Cr	₹61 Cr
₹417 Cr	₹2 Cr	₹4 Cr	₹17 L
₹18 Cr	₹4 Cr	₹2 Cr	₹87 L
₹34 Cr	₹16 Cr	₹16 Cr	₹7 Cr
₹822 Cr	₹200 Cr	₹187 Cr	₹82 Cr
₹249 Cr	₹38 Cr	₹35 Cr	₹5 Cr
₹1416 Cr	₹272 Cr	₹267 Cr	₹134 Cr
₹111	₹35	₹56	₹44
₹111	₹35	₹28	₹22

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023
₹12 Cr	₹20 Cr	₹13 Cr	₹7 Cr
₹31 Cr	₹20 Cr	₹21 Cr	₹12 Cr
₹56 Cr	-₹7 Cr	-₹63 Cr	-₹29 Cr
₹98 Cr	₹34 Cr	-₹30 Cr	-₹10 Cr
₹93 Cr	₹33 Cr	-₹30 Cr	-₹13 Cr
-₹274 Cr	₹44 L	-₹46 Cr	-₹19 Cr
₹596 Cr	-₹36 Cr	₹79 Cr	₹24 Cr
₹415 Cr	-₹2 Cr	₹2 Cr	-₹8 Cr
₹2 Cr	₹4 Cr	₹2 Cr	₹10 Cr
₹417 Cr	₹2 Cr	₹4 Cr	₹2 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Sai Parenteral's Share Price

505.90-15.75 (-3.02%)

+24.70% past 1 Year

Shareholding summary

Promoters

51.16%

FII

4.03%

DII

7.54%

0.98%

Others

36.29%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026
51.16%	51.16%
4.03%	5.73%
7.54%	9.05%
0.98%	3.81%
36.29%	30.25%

Bulk & block deals

Name

Hrti Private Limited

Arihant Capital Markets Limited

Bhaskara Rao Bollineni

Arihant Capital Markets Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
02 Jul 2026	Purchase	6.74 Cr	₹639.68	1.05 L	Bulk	0.238556	NSE
02 Jul 2026	Sell	14.47 Cr	₹637.95	2.27 L	Bulk	0.513441	NSE
09 Apr 2026	Purchase	16.84 Cr	₹423.13	3.98 L	Bulk	0.900892	NSE
07 Apr 2026	Purchase	20.96 Cr	₹409.25	5.12 L	Bulk	1.159462	NSE
02 Apr 2026	Purchase	18.39 Cr	₹407.60	4.51 L	Bulk	1.021322	BSE

Insider trading & SAST

Client name

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type

Sai Parenteral's Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Sai Parenteral's Share Price

Sai Parenteral's Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Sai Parenteral's Share Price

Sai Parenteral's Share Price

Oscillators

Moving averages

Sai Parenteral's Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Sai Parenteral's Share Price

Corporate Actions

Company details

Sai Parenteral's Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Sai Parenteral's Share Price

News

Sai Parenterals Acquires Majority Stake In Hyderabad Research Facility

Sai Parenterals unit Noumed extends Australian OTC pharmacy supply agreement

Sai Parenterals schedules analyst and investor meet on July 3 at 4.30 PM

Sai Parenterals to hold analyst and investor meet on July 2, 2026

Sai Parenterals secures 10-year supply order worth Rs 104.50 crore

Sai Parenterals outlines FY27 manufacturing and product pipeline expansion targets

Sai Parenterals unveils multi-year FY27 capex plan to scale injectables and CDMO exports

Sai Parenterals outlines Rs 440 crores capex plan targeted for completion by FY27

Sai Parenterals sets ambitious FY27 revenue and EBITDA margin targets

Sai Parenterals debuts at 3% premium on the BSE

Sai Parenterals Shares List at Rs 405 on BSE After Issue Price of Rs 392.

Sai Parenteral's Ltd Share Price Today

Sai Parenteral's Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator